Company Profile

BioFire Defense LLC (AKA: Idaho Technology Inc~BioFire Diagnostics LLC)
Profile last edited on: 9/4/2019      CAGE: 088J2      UEI:

Business Identifier: DNA analysis and genotyping
Year Founded
1990
First Award
1994
Latest Award
2009
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

79 W 4500 South Suite 14
Salt Lake City, UT 84106
   (801) 262-3592
   N/A
   www.biofiredefense.com
Location: Single
Congr. District: 04
County: Salt Lake

Public Profile

Formerly located in Idaho City, ID, and doing business as Idaho Technology, the firm was renamed BioFire Diagnostics, LLC and then again renamed as BioFire Diagnostics LLC. Fairly active in the SBIR space until 2009, the firm is providing clinical molecular diagnostic solutions for clinics and laboratories. On offer are FilmArray, a multiplex PCR system that sets the standard for syndromic infectious disease molecular diagnostics; FilmArray Torch, a random access system that is designed to meet laboratory?s syndromic infectious disease testing needs; and FilmArray Pneumonia Panel, designed to aid in the diagnosis of specific agents that cause infections of the lower respiratory tract.. In the Fall of 2013, BioFire Defense, LLC was acquired by bioMerieux SA (a division of Institut Merieux) and now operates as a subsidiary of bioMérieux, Inc.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
250-500
Revenue Range
20M-50M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
75-99

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 2 NIH $850,000
Project Title: Snapback Primers for Genotyping and Mutation Scanning
2009 1 NIH $126,975
Project Title: Characterization Of Respiratory Pathogens In Transplant Patients
2008 2 NIH $834,651
Project Title: Newborn screening for PKU and BH4 responsiveness
2008 1 NIH $147,105
Project Title: Filmarray High Resolution Melting Detection Of Mutations Causing Cystic Fibrosis
2007 2 NIH $848,138
Project Title: Genotype Analysis for Diagnosis of Urea Cycle Disorders

Key People / Management

  Kirk M Ririe -- President

  Philip S Bernard

  Deepika De Silva

  Steven F Dobrowolski

  Kojo S Elenitobajohnson

  David J Eyre

  Rachael Jones -- Vice President Sales and Marketing.

  Mark A Poritz

  Randy P Rasmussen

  David H Teng

  Carl T Wittwer

Company News

There are no news available.